2022 Annual Meeting | P9 - Poster Session 9

Date Monday 04/04/22

Time 05:30 PM - 06:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Education, Research, and Methodology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)

CME Available 0.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT	Abstract	9-001 - A case of a 14 year old male with MOGAD (Myelin Oligocyte Glycoprotein Antibody Disease) post-COVID-19 infection responsive to high dose corticosteroids and intravenous immunoglobulin (IVIG) therapy Alfred Balasa, MD
05:30 PM - 06:30 PM PDT	Abstract	9-002 - MOG Antibody Myelitis Following HIV Seroconversion Sami Kaldawi, DO
05:30 PM - 06:30 PM PDT	Abstract	9-003 - Initial Presentation of MOGAD Masquerading as Acute Para-infectious Flaccid Myelitis Raissa Aoun, MD
05:30 PM - 06:30 PM PDT	Abstract	9-005 - MOG-IgG associated disease is uncommon during treatment with TNF inhibitors Vyanka Redenbaugh, MB BCh BAO
05:30 PM - 06:30 PM PDT	Abstract	9-006 - A Case of MOG-associated Encephalomyelitis in the Setting of Post-COVID-19 Infection Ali-Musa R. Jaffer, MD
05:30 PM - 06:30 PM PDT	Abstract	9-007 - The Role of Socioeconomic, Demographic, and Serologic Factors in Determining the Differential Pathogenesis of Myelin Oligodendrocyte Glycoprotein Antibody Disorder versus Multiple Sclerosis in Pediatric Patients Brian C. Florenzo
05:30 PM - 06:30 PM PDT	Abstract	15-001 - Fear of Brain Tumor in Patients with Migraine in an Academic Headache Clinic Derek J. Notch, MD
05:30 PM - 06:30 PM PDT	Abstract	15-002 - Cerebral Venous Sinus Thrombosis (CVST) As A Complication Of COVID-19 Infection Presenting As Post COVID-19 Headache Mohammad Dibs, MD
05:30 PM - 06:30 PM PDT	Abstract	15-003 - Headache Frequency and Quality of Life in Patients with Post-Acute Sequelae of COVID-19 Sujata P. Thawani, MD
05:30 PM - 06:30 PM PDT	Abstract	15-004 - Occipital Neuralgia Secondary to an Occipital Bone Lesion Revealing Multiple Myeloma Anvita Suneja
05:30 PM - 06:30 PM PDT	Abstract	15-005 - A case of cerebral vasculitis mimicking RCVS Valentina Poretto, MD
05:30 PM - 06:30 PM PDT	Abstract	3-001 - Exploratory Imaging Outcomes of a Phase 1b/2a Clinical Trial of Allopreganolone as a Regenerative Therapeutic for Alzheimer’s Disease: Structural and Functional Connectivity Outcomes Roberta Diaz Brinton, PhD
05:30 PM - 06:30 PM PDT	Abstract	3-003 - Cross-sectional and longitudinal effects of APOE genotype on atrophy and tau burden in atypical Alzheimer’s disease Neha Atulkumar Singh, PhD
05:30 PM - 06:30 PM PDT	Abstract	3-004 - Longitudinal hypothalamic atrophy and its association with amyloid-ß and tau pathology in Alzheimer’s disease Alice Tao
05:30 PM - 06:30 PM PDT	Abstract	3-005 - Computational modeling of tau pathology spread reveals genetic correlates of regional vulnerability and the impact of a LRRK2 mutation Eli Cornblath, MD, PhD
05:30 PM - 06:30 PM PDT	Abstract	12-001 - Diagnosis of myotonia congenita and multiple sclerosis in a patient with a familial history Kara Stavros, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	12-002 - Disease activity after cladribine immune reconstitution therapy: To repeat or to retreat? Kimberley Allen-Philbey, MSc
05:30 PM - 06:30 PM PDT	Abstract	12-003 - Clinical-pathological correlation of progressive solitary sclerosis: a case report Nathan Chu, MD
05:30 PM - 06:30 PM PDT	Abstract	12-004 - Rapidly Progressive Demyelinating Disease Secondary to the Marburg Variant of Multiple Sclerosis: A Case Report Natalie Bartnik, DO
05:30 PM - 06:30 PM PDT	Abstract	12-005 - Small Fiber Neuropathy in People with MS with Neuropathic Pain and Dysautonomia: A Case Series Mary Kelley, DO
05:30 PM - 06:30 PM PDT	Abstract	12-006 - Two-Year Interim Analysis of the TREAT-MS Alemtuzumab Study in Germany Differentiated by Direct Pretreatment Angeliki Konstantinidou
05:30 PM - 06:30 PM PDT	Abstract	12-007 - Updated Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis Brittney Lager
05:30 PM - 06:30 PM PDT	Abstract	12-008 - Diroximel Fumarate (DRF) Has High Rates of Real-World Adherence and Persistence in Patients with Multiple Sclerosis (MS): Retrospective Claims Analysis Nicholas Belviso, PhD, PharmD
05:30 PM - 06:30 PM PDT	Abstract	12-009 - Patients with Multiple Sclerosis Attempting Conception: Interim Analysis from PREG-MS and CANPREG-MS Prospective Pregnancy Registries. Maria K. Houtchens, MD
05:30 PM - 06:30 PM PDT	Abstract	12-010 - Association of Epigenetic Biomarkers of Neoplasia with Multiple Sclerosis in an Underrepresented Minority Population Jeremy M. Bingen
05:30 PM - 06:30 PM PDT	Abstract	12-011 - Impact of symptomatic MS therapy on pregnancy course and outcome Kerstin Hellwig
05:30 PM - 06:30 PM PDT	Abstract	6-001 - Rett-like phenotypes in HNRNPH2-Related Neurodevelopmental Disorder Joseph N. Gonzalez
05:30 PM - 06:30 PM PDT	Abstract	6-002 - Psychophysiological Markers Predict the Effect of Propranolol on Conversational Reciprocity in Autism Spectrum Disorder David Q. Beversdorf, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	6-003 - Utility of General Movement Assessment (GMA) in predicting the neurodevelopmental outcomes of term and late preterm infants exposed to severe hyperbilirubinemia in the neonatal period Chandana Bhagwat, MD
05:30 PM - 06:30 PM PDT	Abstract	6-004 - PFO Closure Following Childhood Stroke Laurel R. Persa, MD
05:30 PM - 06:30 PM PDT	Abstract	6-005 - Shunting Prevalence in Patients with Moyamoya Lori Xu, MD
05:30 PM - 06:30 PM PDT	Abstract	7-001 - Longitudinally Integrated Clerkships and Interwoven Learning Experiences: Adapting Neuroscience Education to Evolving Medical School Curricula Aaron M. Carlson, MD
05:30 PM - 06:30 PM PDT	Abstract	7-002 - The Journey with Our Evolving Neurology Residency Curriculum in Molding Humanistic Neurology Graduates Aileen Antonio, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	7-003 - The impact of an X+Y schedule model on Neurology residency training Shuvro Roy, MD
05:30 PM - 06:30 PM PDT	Abstract	7-004 - A Novel Approach to Orientation for Incoming Neurology Residency through Simulation-Based Education Madeline L. Singer, MD
05:30 PM - 06:30 PM PDT	Abstract	7-005 - Retrospective Study of an Adult Neurology Residency’s Implementation of an Academic Half Day Curriculum Sonali Sharma, MD
05:30 PM - 06:30 PM PDT	Abstract	7-006 - Resident Driven Quality Improvement: A Self-Sustaining Model for New Milestones Micaela R. Owens, DO
05:30 PM - 06:30 PM PDT	Abstract	1-001 - Underutilization of Neuro Critical Care during the COVID-19 Pandemic Shubham Biyani, MBBS
05:30 PM - 06:30 PM PDT	Abstract	1-002 - Delivery of Neurocritical Care Services to Critically Ill Patients with Altered Mental Status Before and During the COVID-19 Pandemic: A Single Center Study Jonathan R. Crowe, MD
05:30 PM - 06:30 PM PDT	Abstract	1-003 - COVID-19 Associated Aortic Thrombosis Mimicking Transverse Myelitis Anand Kumar, DM
05:30 PM - 06:30 PM PDT	Abstract	1-004 - Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes Tia Chakraborty, MD
05:30 PM - 06:30 PM PDT	Abstract	1-005 - Comparison of Invasive and Non-Invasive Brain Tissue Oximetry after Pediatric Traumatic Brain Injury Ann Oh
05:30 PM - 06:30 PM PDT	Abstract	10-001 - Faciobrachial seizures in LGI1 encephalitis are not always dystonic. Noushin C. Foroush, MD
05:30 PM - 06:30 PM PDT	Abstract	10-002 - Incidence and Predictors of in-hospital mortality associated with Status Epilepticus using Nationwide inpatient population cohort database (2011-2014) Tejinder Singh, MD
05:30 PM - 06:30 PM PDT	Abstract	10-004 - National estimate of incidence and predictors of generalized convulsive status epilepticus following traumatic brain injury (TBI) using Nationwide inpatient sample database.(2011-2014) Tejinder Singh, MD
05:30 PM - 06:30 PM PDT	Abstract	10-005 - Continuous Renal Replacement Therapy versus Peritoneal Dialysis in reversing Cefepime-Induced Non-Convulsive Status Epilepticus: A Case Report Noor Mahmoud, MD
05:30 PM - 06:30 PM PDT	Abstract	10-006 - Use of Ketogenic Diet in New-Onset Super-Refractory Status Epilepticus (NOSRSE): A Case Report with Literature Review Daniel Mandel, MD
05:30 PM - 06:30 PM PDT	Abstract	10-007 - Hashimoto Encephalopathy Presenting with Seizures and Uncommon EEG pattern - Case Report Hasmik Amirjanyan, MD
05:30 PM - 06:30 PM PDT	Abstract	4-001 - Peripheral Nervous System Complications of SARS-CoV-2 Chelsea Schmoll, DO
05:30 PM - 06:30 PM PDT	Abstract	4-002 - Case Series: Post-COVID Small Fiber Neuropathy Lindsay S. McAlpine, MD
05:30 PM - 06:30 PM PDT	Abstract	4-003 - Vestibular Dysfunctions Related to COVID-19 Infection: A Clinical Case Report Rebecca Potts
05:30 PM - 06:30 PM PDT	Abstract	4-004 - Dysautonomia in Long Haul Covid-19 Infection Impairs Activities of Daily Living and Mental Health: The Patient Perspective Emma Reford
05:30 PM - 06:30 PM PDT	Abstract	4-005 - Sensory Neuronopathy Following COVID-19 Infection: a Case Series Venkatraman Thulasi, MD
05:30 PM - 06:30 PM PDT	Abstract	4-006 - COVID-19?associated myositis with severe proximal and bulbar weakness Hui Zhang, MD
05:30 PM - 06:30 PM PDT	Abstract	4-007 - Guillain-Barre and Miller Fisher Overlap Syndrome: A Masked Neurological Consequence of COVID-19 Reha Rabbani, MD
05:30 PM - 06:30 PM PDT	Abstract	13-001 - Increased Prevalence of Autoimmune Disease in Individuals with Down Syndrome and Moyamoya Disease Jonathan Santoro, MD
05:30 PM - 06:30 PM PDT	Abstract	13-002 - A Case of Atrioesophageal Fistula as a Rare Complication of Atrial Fibrillation Ablation Leading to Multifocal Embolic Ischemic Strokes Merry Huang, MD
05:30 PM - 06:30 PM PDT	Abstract	13-003 - Early Onset Cerebral Amyloid Angiopathy in the Context of Perinatal Hydrocephalus and VP Shunt Instrumentation Joshua A. Modeste
05:30 PM - 06:30 PM PDT	Abstract	13-004 - Sex-specific lesion pattern of long-term functional outcome after stroke Anna K. Bonkhoff, MD
05:30 PM - 06:30 PM PDT	Abstract	13-005 - P2RX7 stimulates Mac-1/ICAM-1-dependent leukocyte-endothelial Adhesion through promotion of Neurovascular Insult during Septic Encephalopathy Muhammad Masood Ahmed, PhD
05:30 PM - 06:30 PM PDT	Abstract	13-006 - Thrombotic Thrombocytopenic Purpura Atypically Presenting as Acute Ischemic Stroke Sukriye Damla Kara, MD
05:30 PM - 06:30 PM PDT	Abstract	13-007 - Do Retinal Microvascular Changes Improve TIA Risk Stratification Scores? ABCD2 vs. ABCDEye in the FOTO-TIA Study Beau B. Bruce, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	13-008 - “Early Mobilization Protocol” Can Be Initiated in the Intensive Care Unit in Acute Ischemic Stroke Patients After Receiving Intravenous Alteplase Sachin M. Bhagavan, MD
05:30 PM - 06:30 PM PDT	Abstract	13-009 - Application of Machine Learning Model to Prognosticate Functional Outcome in Patients with Acute Ischemic Stroke Secondary to Proximal Large Vessel Occlusion Sankar P. Gorthi, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	13-010 - Incidence of Access Site Complications in Patients Receiving Tenecteplase as Bridging Therapy to Endovascular Treatment
05:30 PM - 06:30 PM PDT	Abstract	5-001 - Dose Patterns for Long-Term Deutetrabenazine Treatment in Patients With Tardive Dyskinesia by Baseline Abnormal Involuntary Movement Scale Item 8 Score Nayla Chaijale
05:30 PM - 06:30 PM PDT	Abstract	5-002 - Effects of Long-Term Deutetrabenazine Treatment in Patients With Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders Nayla Chaijale
05:30 PM - 06:30 PM PDT	Abstract	5-003 - Evaluation of brain SPECT with 99mTc - TRODAT-1 in the differential diagnosis of Parkinsonism
05:30 PM - 06:30 PM PDT	Abstract	5-004 - Role of Nuclear Imaging (18-Fluro-FDG PET Brain and 99m-TC-TRODAT-1-SPECT Brain) in Supporting the Clinical Diagnosis in Patients with Idiopathic Parkinson's Disease, Progressive Supranuclear Palsy and Vascular Parkinsonism , along with their Characteristic Imaging Findings
05:30 PM - 06:30 PM PDT	Abstract	5-005 - Liraglutide Improves Non-Motor Function and Activities of Daily Living in Patients with Parkinson's disease: A Randomized, Double-Blind, Placebo-Controlled Trial Michele Tagliati, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	5-006 - Parkinson's Progression Markers Initiative (PPMI) Online expands biomarker research in Parkinson's disease (PD) Ethan G. Brown, MD
05:30 PM - 06:30 PM PDT	Abstract	5-007 - Real-world Effect of Age on Long-term Effectiveness and Safety of Levodopa-Carbidopa Intestinal Gel: A Post Hoc Analysis From the Prospective, Multinational, Observational DUOGLOBE Study Lars Bergmann
05:30 PM - 06:30 PM PDT	Abstract	2-001 - A systemic review of neurological manifestations of COVID-19 infection Sahil Naik, MD
05:30 PM - 06:30 PM PDT	Abstract	2-002 - Cerebral Venous Sinus Thrombosis (CSVT) and Bilateral Thalamic Infarcts Following Pfizer-BioNTech mRNA Vaccine in a Patient with Ulcerative Colitis Natalie Bartnik, DO
05:30 PM - 06:30 PM PDT	Abstract	2-003 - Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection Praveen Ramani, MBBS
05:30 PM - 06:30 PM PDT	Abstract	2-004 - 69-Year-Old with Flaccid Paraplegia Immediately Post Epidural Steroid Injection Hayden Wisely, DO
05:30 PM - 06:30 PM PDT	Abstract	2-005 - Single Neuron Recruitment during Direct Electrical Stimulation in the Human Cortex
05:30 PM - 06:30 PM PDT	Abstract	11-001 - Amyloidosis Presenting as Mononeuropathy Multiplex Michael D. Weiss, MD, FAAN
05:30 PM - 06:30 PM PDT	Abstract	11-002 - Chronic Inflammatory Demyelinating Polyneuropathy at a reference center in a low income country: Eleven year’s experience Marco A. Alvarado, Jr.
05:30 PM - 06:30 PM PDT	Abstract	11-003 - Idiopathic Brachial Plexopathy Presenting with Unilateral Vocal Cord Paresis Marjorie Anne D. Bagnas, MD
05:30 PM - 06:30 PM PDT	Abstract	11-004 - Carpal and Cubital Tunnel Surgical Release in HNPP and CMT1A: Success Predictors and Outcomes Pitcha Chompoopong, MD
05:30 PM - 06:30 PM PDT	Abstract	11-005 - Conus Medullaris Damage by West Nile Virus Infection Ghadeer Fatani, MBBS
05:30 PM - 06:30 PM PDT	Abstract	11-006 - Chronic Inflammatory Demyelinating Polyradiculoneuropathy associated with Enfortumab Vedotin Ali Ebrahim, MD
05:30 PM - 06:30 PM PDT	Abstract	11-007 - A Unique Presentation of Amyloid-like IgM Deposition Neuropathy with Microvasculitis. Pannathat Soontrapa, MD
05:30 PM - 06:30 PM PDT	Abstract	11-008 - Acute and Chronic Demyelinating Neuropathies following COVID-19 Vaccination: A Report of Four Cases Erin Dennis, MD
05:30 PM - 06:30 PM PDT	Abstract	11-009 - A rare case of bilateral Bell's Palsy in the setting of SARS-CoV-2 Yulia Salamatova, MD
05:30 PM - 06:30 PM PDT	Abstract	11-010 - Association between Sarcopenia and Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis. Thapat Wannarong, MD

Faculty Disclosures
Echo Tan, MD	Dr. Tan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Lindsay S. McAlpine, MD	Dr. McAlpine has received personal compensation in the range of $50,000-$99,999 for serving as a T32 Grant Fellow with NIH.
Stefanie J. Rodenbeck, MD	Dr. Rodenbeck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Nicholas Belviso, PhD, PharmD	Dr. Belviso has received personal compensation for serving as an employee of Biogen.
Naveen Sankhyan, MD, MBBS, DM	The institution of Dr. Sankhyan has received research support from PTC Therapeutics for a Multicentric RCT. Dr. Sankhyan has received research support from Institute Grant, PGIMER, (Goverment Entity).
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Brittney Lager	Brittney Lager has received personal compensation for serving as an employee of AcariaHealth.
Charles J. Kidd, MD	Dr. Kidd has nothing to disclose.
Trevor Hawkins, MD	Dr. Hawkins has nothing to disclose.
Syed Rizvi, MD	Dr. Rizvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono Roche Bristol Myers . Dr. Rizvi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Na.
Sabrina Marangoni	No disclosure on file
Jennifer Whitwell, PhD	Dr. Whitwell has nothing to disclose.
John Chen	No disclosure on file
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainomix. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Rabinstein has received research support from Chiesi. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
	No disclosure on file
Alice Tao	Ms. Tao has nothing to disclose.
Maria K. Houtchens, MD	Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech.
Krishna Nalleballe, MD, FAAN	Dr. Nalleballe has nothing to disclose.
Susan Shin, MD	Dr. Shin has nothing to disclose.
Rebecca Potts	Ms. Potts has nothing to disclose.
Michael Carrithers, MD, PhD	The institution of Dr. Carrithers has received research support from Biogen.
Abdallah O. Amireh, MD	Dr. Amireh has nothing to disclose.
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Shivanee Sodani, MBBS	Dr. Sodani has nothing to disclose.
Jose R. Lopez-Castellanos, MD	Dr. Lopez-Castellanos has nothing to disclose.
Jonathan R. Crowe, MD	Dr. Crowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emergency Call for Heart Attack and Stroke.
Lana Chahine, MD, FAAN	Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Shumaila Andleeb, Pharm-D	No disclosure on file
Machteld E. Hillen, MD, FAAN	The institution of Dr. Hillen has received research support from Genentech.
Sara Mariotto, MD, PhD	Dr. Mariotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, TSF, Dynamics. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF.
Narenraj Arulprakash, MD	Dr. Arulprakash has nothing to disclose.
Joshua A. Modeste	Mr. Modeste has nothing to disclose.
Neha Atulkumar Singh, PhD	Dr. Singh has nothing to disclose.
Madeline L. Singer, MD	Dr. Singer has nothing to disclose.
Anvita Suneja	Miss Suneja has nothing to disclose.
Yulia Salamatova, MD	Dr. Salamatova has nothing to disclose.
Gloria Chiang	No disclosure on file
Akshaya Prabhakaran Sudha, MBBS	Dr. Prabhakaran Sudha has nothing to disclose.
Muhammad F. Ishfaq, MD	Dr. Ishfaq has nothing to disclose.
Marie C. Eugene, DO	Dr. Eugene has nothing to disclose.
Bruno Giometto, MD	Dr. Giometto has nothing to disclose.
Benjamin Meyer	Mr. Meyer has nothing to disclose.
Shaul Shaulov, MD	Dr. Shaulov has nothing to disclose.
Fadi B. Nahab, MD	Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Merry Huang, MD	Dr. Huang has nothing to disclose.
Alexis N. Simpkins, MD, PhD, MSCR, FAAN	Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Neurological Disorders and Stroke Data Safety Monitoring Board. Dr. Simpkins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. The institution of Dr. Simpkins has received research support from NIH/NIA. The institution of Dr. Simpkins has received research support from Bristol-Meyer Squibb Foundation. Dr. Simpkins has received publishing royalties from a publication relating to health care.
Shruthi H. Pulimamidi	Dr. Pulimamidi has nothing to disclose.
Lokesh Saini, DM	Dr. Saini has nothing to disclose.
Nathan Chu, MD	Dr. Chu has nothing to disclose.
Justin Hoskin, MD	Dr. Hoskin has nothing to disclose.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Jonathan Perk, MD, PhD, FAAN	Dr. Perk has nothing to disclose.
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Mohammad Dibs, MD	Dr. Dibs has nothing to disclose.
Kelsey Hillhouse, MD	Dr. Carr has nothing to disclose.
Fabio F. Toso, MD	Dr. Toso has nothing to disclose.
Runi Tanna	Miss Tanna has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Jose A. Montes-Rivera, MD, FAAN	Dr. Montes-Rivera has nothing to disclose.
Raissa Aoun, MD	Dr. Aoun has nothing to disclose.
Pariwat Thaisetthawatkul, MD, FAAN	Dr. Thaisetthawatkul has nothing to disclose.
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ziemssen has received research support from Biogen. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from Celgene.
Jeremy M. Bingen	Mr. Bingen has nothing to disclose.
Anna L. Bazan, MD	Dr. Bazan has nothing to disclose.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.
Farah Y. Fourcand, MD	Dr. Fourcand has nothing to disclose.
Frank Hoffmann, MD	Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Talecris. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Timothy E. Ryan, Jr., MD	The institution of Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda Pharmaceuticals. Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Nakul Katyal, MD	Dr. Katyal has nothing to disclose.
Thomas L. Davis, MD	Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation.
Reha Rabbani, MD	Ms. Rabbani has nothing to disclose.
Sameera Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Esther Cubo Delgado, MD, FAAN	Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Eugenia Ho, MD	No disclosure on file
Sharmilee Gnanapavan, MB	Dr. Gnanapavan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Gnanapavan has received research support from NIHR.
Andrew D. Siderowf, MD	Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase.
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Voyager. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Prelinia. The institution of Dr. Factor has received research support from Medtronics. The institution of Dr. Factor has received research support from Boston Scientific. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Ronald J. Gathagan II	Mr. Gathagan has nothing to disclose.
Michael S. Rafii, MD, PhD	Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.
Orlando Povoas Barsottini, MD	No disclosure on file
Sarah Lee, MD	Dr. Lee has nothing to disclose.
Ghadeer Fatani, MBBS	Dr. Fatani has nothing to disclose.
Sahar Zafar, MD	Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corticare. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Thapat Wannarong, MD	Dr. Wannarong has nothing to disclose.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN	Dr. Sankaraneni has nothing to disclose.
Pannathat Soontrapa, MD	The institution of Dr. Soontrapa has received research support from Argenx.
Mary Kelley, DO	Dr. Kelley has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN	An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Sydney Cash, MD	Dr. Cash has received stock or an ownership interest from Beacon Biosignals.
Michael M. Dowling, MD, PhD, FAAN	Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Dowling has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NHLBI. The institution of Dr. Dowling has received research support from NIH.
Subramanian Muthusamy, MBBS	Dr. Muthusamy has nothing to disclose.
James N. Brenton, MD	Dr. Brenton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for I-ACT on a Novartis sponsored project. The institution of Dr. Brenton has received research support from NIH/NINDS. The institution of Dr. Brenton has received research support from Autoimmune Encephalitis Alliance. Dr. Brenton has received publishing royalties from a publication relating to health care. Dr. Brenton has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Dr. Brenton has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with FDA.
Matthew Koster	No disclosure on file
Jessica K. Alexander, PhD	Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
Lidia Maria V. Moura, MD, PhD, MPH, FAAN	Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for eNova. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. The institution of Dr. Moura has received research support from NIH-NIA - 1K08AG053380-01A1. The institution of Dr. Moura has received research support from NIH-NIA 5R01AG062282-02 . The institution of Dr. Moura has received research support from NIH-NIA 2P01AG032952-11 . The institution of Dr. Moura has received research support from NIH- NIA 3R01AG062282-03S1 . The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America .
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Lisena Hasanaj	Ms. Hasanaj has nothing to disclose.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Paul E. Youssef, DO	Dr. Youssef has nothing to disclose.
Ali Ebrahim, MD	Dr. Ebrahim has nothing to disclose.
Costantino Iadecola, MD	Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.
Nanan Nuraini	No disclosure on file
Yunxia Wang, MD, FAAN	Dr. Wang has nothing to disclose.
Charles C. Flippen II, MD, FAAN	Dr. Flippen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Carelon. Dr. Flippen has a non-compensated relationship as a committee member with American Headache Society that is relevant to AAN interests or activities. Dr. Flippen has a non-compensated relationship as a committee/task force member with American Neurological Association that is relevant to AAN interests or activities.
Abhilash Thatikala, MD, MBBS, DM	Dr. Thatikala has nothing to disclose.
Serena Spudich, MD	The institution of Dr. Spudich has received research support from NIH.
Derek J. Notch, MD	Dr. Notch has nothing to disclose.
Nasar Ali, DO	Dr. Ali has nothing to disclose.
Sandra Thiel	Ms. Thiel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer Healthcare .
Siddhart K. Mehta, MD	Dr. Mehta has nothing to disclose.
Srinivasa Rao Kundeti	Srinivasa Rao Kundeti has nothing to disclose.
Monica Korell, MPH	Ms. Korell has nothing to disclose.
Daniel Li, MD	Mr. Li has nothing to disclose.
Zhiyv Niu, PhD, FACMG	Zhiyv Niu has nothing to disclose.
Marieta Anca-Herschkovitsch, MD	Marieta Anca-Herschkovitsch, MD has nothing to disclose.
James F. Selwa, MD, MBA	Dr. Selwa has nothing to disclose.
Venkatraman Thulasi, MD	Dr. Thulasi has nothing to disclose.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Eric Dunn, DO	Dr. Dunn has nothing to disclose.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Tejas Ranade, MD	Dr. Ranade has nothing to disclose.
Jawad F. Kirmani, MD	Dr. Kirmani has nothing to disclose.
Nidhi Kapoor, MD, MBBS	Dr. Kapoor has nothing to disclose.
George Banks, MD	Dr. Banks has nothing to disclose.
Pitcha Chompoopong, MD	Dr. Chompoopong has nothing to disclose.
Maher Fakhouri, MD	Dr. Fakhouri has nothing to disclose.
Deepika Joshi, MD	Dr. Joshi has nothing to disclose.
Melanie Manning	No disclosure on file
Stephan Richter	The institution of Stephan Richter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Stephan Richter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. The institution of Stephan Richter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Darmstadt. The institution of Stephan Richter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Stephan Richter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
Mellad Khoshnood, MD	Dr. Khoshnood has nothing to disclose.
Wan Yee Kong, MBBS	Dr. Kong has nothing to disclose.
Arpan Patel, MBBS	Dr. Patel has nothing to disclose.
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Ami Cuneo, MD	Dr. Cuneo has nothing to disclose.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INC research . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from TEVA.
Spencer Nam, MD	Dr. Nam has nothing to disclose.
Ushtar Amin, MD	Dr. Amin has nothing to disclose.
Brian L. Appavu, MD	Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Laura Quint	Laura Quint has received personal compensation for serving as an employee of Sanofi-Aventis Deutschland GmbH.
Stacy Finkbeiner	Stacy Finkbeiner has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Joseph C. Alario, DO	Dr. Alario has nothing to disclose.
Chandana Bhagwat, MD	Dr. Bhagwat has nothing to disclose.
Hasmik Amirjanyan, MD	Dr. Amirjanyan has nothing to disclose.
Stephen Weigand	No disclosure on file
Maureen E. Stabio, PhD	Dr. Stabio has received publishing royalties from a publication relating to health care.
Ashlea Lucas, PA	Ms. Lucas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Ms. Lucas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers Squibb.
Helio Afonso G. Teive, MD	Dr. Teive has nothing to disclose.
Sylvie Goldman, PhD	Dr. Goldman has nothing to disclose.
Shuvro Roy, MD	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Mark F. Gordon, MD, FAAN	Dr. Gordon has received personal compensation for serving as an employee of Teva. Dr. Gordon has stock in Teva.
Michele Tagliati, MD, FAAN	Dr. Tagliati has received publishing royalties from a publication relating to health care.
Olivia Thornburg	Olivia Thornburg has nothing to disclose.
Muhammad H. Jaffer, MD	Dr. Jaffer has nothing to disclose.
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Human Biosciences. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Stalicla. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scioto. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from BionexusKC. The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $10,000-$49,999 for serving as a Case Consultant with Best Doctors.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Aaron M. Carlson, MD	Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Markus D. Schirmer, PhD	Dr. Schirmer has nothing to disclose.
Livia A. Dutra, MD	Dr. Dutra Antonio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Dutra Antonio has received research support from Hospital Israelita Albert Einstein.
Ona Wu	No disclosure on file
Andrea Boon, MD	Dr. Boon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HPE cosmetics .
Kamal Shouman, MD	Dr. Shouman has nothing to disclose.
Angeliki Konstantinidou	Miss Konstantinidou has received personal compensation for serving as an employee of Sanofi-Aventis Deutschland GmbH.
Paolo Solla, MD	Dr. Solla has nothing to disclose.
Leorah A. Freeman, MD, PhD	Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for WebMD. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MSAA. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Participant in educational interview with Multiple Sclerosis Association of America.
Sujata P. Thawani, MD	Dr. Thawani has nothing to disclose.
Adrienne M. Keener, MD	Dr. Keener has nothing to disclose.
Carrina Appling	No disclosure on file
Udaya K. Seneviratne, MD	Dr. Seneviratne has nothing to disclose.
Eduardo S. Tolosa, MD	Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prevail. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MSD . Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie . Dr. Tolosa has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ever Neuropharm. Dr. Tolosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esteve. The institution of Dr. Tolosa has received research support from Instituto de Salud CArlos III. Dr. Tolosa has received research support from MJFF. Dr. Tolosa has received publishing royalties from a publication relating to health care.
Kunal Bhatia, MD	Dr. Bhatia has nothing to disclose.
Parisha Bhatia, MD	Dr. Bhatia has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
Natalie Bartnik, DO	Dr. Bartnik has nothing to disclose.
Varun K. Singh, MD, MBBS	Dr. Singh has nothing to disclose.
Mohamed Ridha, MD	Dr. Ridha has nothing to disclose.
Hayden Wisely, DO	Dr. Wisely has nothing to disclose.
Mihaela A. Simu, MD, PhD	Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis PHarma . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Romania. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson &Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofy Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ABBVIE. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi Romania. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Johnson&Johnson. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson . Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Simu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ewopharma A G. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Simu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen.
Huiam Mubarak, MD	Dr. Mubarak has nothing to disclose.
Andrea I. Ciplea	An immediate family member of Ms. Ciplea has received personal compensation for serving as an employee of Astra Zeneca. Ms. Ciplea has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Bayer Healthcare. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of travel-related expenses with Novartis. Ms. Ciplea has received personal compensation in the range of $0-$499 for serving as a payment of congress fees with Teva.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Anthony Noto, MD	Dr. Noto has nothing to disclose.
Varsha Muddasani, MBBS	Dr. Muddasani has nothing to disclose.
Valerie Sharf, MD	Dr. Sharf has nothing to disclose.
Bin Zhang	No disclosure on file
Elia Sechi, MD	Dr. Sechi has nothing to disclose.
Micaela R. Owens, DO	Dr. Owens has nothing to disclose.
Aileen Antonio, MD, FAAN	Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from AAN.
Sahil Naik, MD	Dr. Naik has nothing to disclose.
Werner Poewe, MD	Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Adeel Zubair, MD	Dr. Zubair has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The MedNet.
Varun Kumar, MD	Dr. Kumar has nothing to disclose.
Roberta J. Seidman, MD	Dr. Seidman has nothing to disclose.
Jennifer A. Frontera, MD	Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Alexander Abud, MD	Dr. Abud has nothing to disclose.
Zoe O. Marinides, MD	Dr. Marinides has nothing to disclose.
David G. Standaert, MD, PhD, FAAN	Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium Pharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gray Matter Technologies. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from Department of Defense. The institution of Dr. Standaert has received research support from National Institutes of Health. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Case Western Reserve. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant with California Pacific Medical Center. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Course Instructor with International Parkinson Disease and Movement Disorders Society. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Parkinson Study Group. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Speaker with UCSD. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Warren Alpert Foundation. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities.
Penelope S. Smyth, MD	Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Canada. Dr. Smyth has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Short Term Exceptional Drug Therapy Program Alberta. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen-Idec. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Smyth has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals.
Christopher L. Kramer, MD	Dr. Kramer has nothing to disclose.
Helen Onuorah, Other	Ms. Onuorah has nothing to disclose.
Joshua A. Kornbluth, MD	Dr. Kornbluth has received personal compensation for serving as an employee of Tufts Medical Center. Dr. Kornbluth has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for ERI. Dr. Kornbluth has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. The institution of Dr. Kornbluth has received research support from Vivonics, Inc.
Priyank Patel, MD	Dr. Patel has nothing to disclose.
Sindhu Sahito, MD	Dr. Sahito has nothing to disclose.
Musab Zorlu, MD	Dr. Zorlu has nothing to disclose.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Rene D. Gleizer, Jr., MD	Dr. Gleizer has nothing to disclose.
Valentina Poretto, MD	Dr. Poretto has nothing to disclose.
Alfred Balasa, MD	Dr. Balasa has nothing to disclose.
Camille Malatt, MD	Dr. Malatt has nothing to disclose.
Anthony L. Fine, MD	The institution of Dr. Fine has received research support from Neurocrine Biosciences. The institution of Dr. Fine has received research support from UCB. The institution of Dr. Fine has received research support from American Board of Psychiatry and Neurology.
Daniah Shamim, MD	Dr. Shamim has nothing to disclose.
Ann Oh	Dr. Oh has nothing to disclose.
Yaacov Anziska, MD	Dr. Anziska has nothing to disclose.
Monica Marta	Monica Calado-Marta has nothing to disclose.
Christopher Coffey, PhD, FAAN	Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Noushin C. Foroush, MD	Dr. Foroush has nothing to disclose.
Elizabeth A. Hartman, MD	An immediate family member of Dr. Hartman has stock in Amgen.
Sami Kaldawi, DO	Dr. Kaldawi has nothing to disclose.
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Catherine Miller	Catherine Miller has received personal compensation for serving as an employee of Biogen. Catherine Miller has received stock or an ownership interest from Biogen.
Roberta Diaz Brinton, PhD	Roberta Diaz Brinton, PhD has nothing to disclose.
Yvette Bordelon, MD, FAAN	Dr. Bordelon has nothing to disclose.
Christopher Morgan, MD	Dr. Morgan has nothing to disclose.
Giorgio Fabiani, MD	Dr. Fabiani has nothing to disclose.
Valentina Stephen Joseph, MD	Dr. Joseph has nothing to disclose.
Brandi R. French, MD	Dr. French has nothing to disclose.
Marco A. Alvarado, Jr.	Dr. Alvarado has nothing to disclose.
Spozhmy Panezai, MD	Dr. Panezai has nothing to disclose.
Christopher D. Geiger, MD	Dr. Geiger has nothing to disclose.
Jason B. Richards, MD	The institution of Dr. Richards has received research support from Brown Physicians, Inc.
Ezequiel A. Piccione, MD, FAAN	Dr. Piccione has nothing to disclose.
Emma Reford	Ms. Reford has nothing to disclose.
Camilo R. Gomez, MD, FAAN	Dr. Gomez has nothing to disclose.
Nayla Chaijale	Nayla Chaijale has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Jason Mendoza	No disclosure on file
David Anson, MD	Dr. Anson has nothing to disclose.
Maria Shoaib, MD	Dr. Shoaib has nothing to disclose.
Pearce Korb, MD, FAAN	Dr. Korb has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Resources.
Roseanne D. Dobkin, PhD	Dr. Dobkin has nothing to disclose.
Natalia S. Rost, MD, MPH, FAHA, FAAN	Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Vyanka Redenbaugh, MB BCh BAO	Dr. Redenbaugh has nothing to disclose.
Sean J. Pittock, MD	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Anand Kumar, DM	Dr. Kumar has nothing to disclose.
Nicolas A. Bianchi, MD	Dr. Bianchi has received personal compensation in the range of $0-$499 for serving as a Consultant for Innovation Hub Enterprises, LLC. The institution of Dr. Bianchi has received research support from Emory Medical Care Foundation.
Nirubol Tosakulwong	No disclosure on file
Hui Zhang, MD	Dr. Zhang has nothing to disclose.
Carl DeMoor	Carl DeMoor has received personal compensation for serving as an employee of Biogen. Carl DeMoor has received stock or an ownership interest from Biogen. An immediate family member of Carl DeMoor has received personal compensation in the range of $100,000-$499,999 for serving as a Program Director with NIH.
Praveen Ramani, MBBS	Dr. Ramani has nothing to disclose.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Daniel Krashin, MD	Dr. Krashin has nothing to disclose.
Kenneth Dalton III, MD	Dr. Dalton has nothing to disclose.
Sara A. McGuire, MD	Dr. McGuire has nothing to disclose.
Sameer Sharma, MD, MBBS	Dr. Sharma has nothing to disclose.
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Virginia Lee, PhD	Virginia Lee, PhD has nothing to disclose.
Elliot J. Hogg, MD	Dr. Hogg has nothing to disclose.
Wilmot Bonnet, MD	Dr. Bonnet has nothing to disclose.
Nancy J. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurophth. The institution of Dr. Newman has received research support from GenSight. The institution of Dr. Newman has received research support from Chiesi/Santhera. The institution of Dr. Newman has received research support from NINDS/NIH. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Sonali Sharma, MD	Dr. Sharma has nothing to disclose.
Marjorie Anne D. Bagnas, MD	Dr. Bagnas has nothing to disclose.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Cynthia Correll, MD	Dr. Correll has nothing to disclose.
Isabelle Snider	Ms. Snider has nothing to disclose.
Nivedita Jha, MD, MBBS	Dr. Jha has nothing to disclose.
M. Tariq Bhatti, MD	Dr. Bhatti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Receptos . Dr. Bhatti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH LHON gene therapy study .
Laura Witt	No disclosure on file
Christopher Schwarz	No disclosure on file
Eli Cornblath, MD, PhD	Mr. Cornblath has nothing to disclose.
Doris Xia, DO	Dr. Xia has nothing to disclose.
Joohi Jimenez Shahed, MD	Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bracket Global LLC. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Omega. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. The institution of Dr. Jimenez Shahed has received research support from Michael J Fox Foundation. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with American Academy of Neurology. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on Research Grant with Florida Atlantic University. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Speaker with Tourette Association of America. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with NACCME.
Kelly Breaux, MD	Dr. Breaux has nothing to disclose.
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Zeinab Charmchi, MD	Dr. Charmchi has nothing to disclose.
Megan E. Esch, MD	Dr. Esch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Esch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Esch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Esch has received research support from PCORI.
Laurel R. Persa, MD	Dr. Persa has nothing to disclose.
Kimberley Allen-Philbey, MSc	Miss Allen-Philbey has nothing to disclose.
Jason L. Aldred, MD, FAAN	Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Atara. The institution of Dr. Aldred has received research support from Takeda. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Theravance. The institution of Dr. Aldred has received research support from Triplet Therapeutics. The institution of Dr. Aldred has received research support from UCB. The institution of Dr. Aldred has received research support from Cerevel . The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from Athira. The institution of Dr. Aldred has received research support from IRL. The institution of Dr. Aldred has received research support from NeuroDerm.
Ryan Pinosky	Mr. Pinosky has nothing to disclose.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Shannon M. LaBoy, MD	Dr. LaBoy has nothing to disclose.
Ameen Fahad, DO	Dr. Fahad has nothing to disclose.
Karen E. Anderson	Ms. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for teva. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Biogen. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Ms. Anderson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for neurocrine. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medscape. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for atheneum. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GLG. Ms. Anderson has received personal compensation in the range of $500-$4,999 for serving as a scientific advisor with CHDI.
Hongyan Li, MD, PhD, FAAN	Dr. Li has nothing to disclose.
Daniel Weintraub	Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Vishank A. Shah, MD	Dr. Shah has nothing to disclose.
Shubham Biyani, MBBS	Dr. Biyani has nothing to disclose.
Chelsea Schmoll, DO	Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . Dr. Schmoll has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Schmoll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Ali-Musa R. Jaffer, MD	Dr. Jaffer has nothing to disclose.
Paul M. Bourgeois, MD	Dr. Bourgeois has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE.
Chirag N. Savani, MD	No disclosure on file
Ethan G. Brown, MD	Dr. Brown has received personal compensation in the range of $0-$499 for serving as a Consultant for Rune Labs, Inc. An immediate family member of Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Brown has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brown has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Knowledge Plus. The institution of Dr. Brown has received research support from Michael J. Fox Foundation. The institution of Dr. Brown has received research support from NIH.
Caroline M. Tanner, MD, PhD, FAAN	Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Kenneth L. Marek, MD	Dr. Marek has received personal compensation for serving as an employee of IND. Dr. Marek has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for invicro. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for takeda. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Koneksa. Dr. Marek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xingimaging. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Marek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Marek has received research support from Michael J Fox Foundation.
Connie C. Marras, MD	Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Deepti Nagesh, MBBS	Dr. Nagesh has nothing to disclose.
Mohammed Al-Dulaimi, MD	Dr. Al-Dulaimi has nothing to disclose.
Jeta Pol-Patil, Research Assistant	Ms. Pol-Patil has nothing to disclose.
Elina Zakin, MD	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Kevin Elmore, MD	Dr. Elmore has nothing to disclose.
Swathi Beladakere Ramaswamy, MD	Dr. Beladakere Ramaswamy has nothing to disclose.
Jennifer Bain, MD, PhD	Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Bain has received personal compensation in the range of $0-$499 for serving as a Consultant for M3 Consulting. Dr. Bain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Legal Company . Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grin Therapeutics. Dr. Bain has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for New York University. Dr. Bain has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for SUNY Donwstate. The institution of Dr. Bain has received research support from Yellow Brick Road Project. The institution of Dr. Bain has received research support from To Cure a Rose Foundation.
Bruna Dias, MD	Bruna Dias has nothing to disclose.
Christopher P. Kellner, MD	Dr. Kellner has stock in METIS Innovative. Dr. Kellner has stock in Precision Recovery. Dr. Kellner has stock in Synchron. Dr. Kellner has stock in Fluid BioMed. Dr. Kellner has stock in Proprio. Dr. Kellner has stock in Von Vascular. Dr. Kellner has stock in E8. Dr. Kellner has stock in Borvo. Dr. Kellner has stock in Phantom Neuro. The institution of Dr. Kellner has received research support from Integra. The institution of Dr. Kellner has received research support from Penumbra. The institution of Dr. Kellner has received research support from Viz.AI. The institution of Dr. Kellner has received research support from ICE Neurosystems. The institution of Dr. Kellner has received research support from Irras. The institution of Dr. Kellner has received research support from Microtransponder. The institution of Dr. Kellner has received research support from Medtronic. The institution of Dr. Kellner has received research support from Longeviti. The institution of Dr. Kellner has received research support from Endostream. The institution of Dr. Kellner has received research support from CVAID.
Lucas H. Nalley, NP	Mr. Nalley has nothing to disclose.
Katherine C. Nickels, MD, FAAN	The institution of Dr. Nickels has received research support from Zogenix. The institution of Dr. Nickels has received research support from Marinus. The institution of Dr. Nickels has received research support from Bio-Pharm Solutions. The institution of Dr. Nickels has received research support from Pediatric Epilepsy Research Foundation. Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving as a Faculty with J. Kiffin Penry Educational Programs.
Neena Viswanathan, MD	Dr. Viswanathan has nothing to disclose.
Valerie Biousse, MD	Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurophoenix. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Beau B. Bruce, MD, FAAN	Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
Ethan I. Meltzer, MD	Dr. Meltzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. Meltzer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Meltzer has received research support from Genentech. Dr. Meltzer has received publishing royalties from a publication relating to health care.
Hannah R. Daniels, BS	Ms. Daniels has nothing to disclose.
James B. Lewin, PharmD	Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Makoto Ishii, MD, PhD	Dr. Ishii has stock in Regeneron Pharmaceuticals. The institution of Dr. Ishii has received research support from NIH. The institution of Dr. Ishii has received research support from BrightFocus Foundation. The institution of Dr. Ishii has received research support from Alzheimer's Association. Dr. Ishii has received personal compensation in the range of $0-$499 for serving as a Author/Contributor with Relias Media.
Nicolas Madigan, MD	Dr. Madigan has nothing to disclose.
Alyssa M. Smith, MD	Dr. Smith has nothing to disclose.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Persen Sukpornchairak, MD	Dr. Sukpornchairak has nothing to disclose.
JaNean Engelstad	No disclosure on file
Eelco F. Wijdicks, MD, FAAN	Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Sheyar Amin, MD	Dr. Amin has nothing to disclose.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Juha M. Savola, MD, PhD	Dr. Savola has received personal compensation for serving as an employee of Teva Pharmaceuticals. Dr. Savola has received intellectual property interests from a discovery or technology relating to health care.
Haralabos Zacharatos, MD	Dr. Zacharatos has nothing to disclose.
Maryann Mays, MD, FAAN	Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mays has received research support from Amgen.
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Jonathan Santoro, MD	Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.
Sohini Chowdhury	No disclosure on file
Lori Xu, MD	Dr. Xu has nothing to disclose.
Sarah E. Berini, MD	Dr. Berini has nothing to disclose.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Amanda Wilhelm, PhD	Dr. Wilhelm has received personal compensation for serving as an employee of Teva Pharmaceuticals .
Norbert Kovacs	No disclosure on file
Michael D. Weiss, MD, FAAN	Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Katherine Fu, MD	Dr. Fu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology: Neurology Journal .
Yushan Pan	Ms. Pan has nothing to disclose.
Romana Hoeftberger	Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun, Biogen, Sanofi-Aventis, and UCB Biopharma.
Gary Steinberg, MD, PhD	Dr. Steinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SanBio. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zeiss. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgical Theater. Dr. Steinberg has received research support from National Institutes of Health. Dr. Steinberg has received research support from California Institute of Regenerative Medicine. Dr. Steinberg has received intellectual property interests from a discovery or technology relating to health care.
Kara Stavros, MD, FAAN	Dr. Stavros has nothing to disclose.
Gerson D. Hernandez Rivera, MD, MPH	Dr. Hernandez Rivera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuTherapeutics. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging. The institution of Dr. Hernandez Rivera has received research support from National Institute on Aging.
Manali Desai, DO	Dr. Desai has nothing to disclose.
Daniel Mandel, MD	Dr. Mandel has nothing to disclose.
Shivani Naik, MD	Dr. Naik has nothing to disclose.
Anudeep Yelam, MD	Dr. yelam has nothing to disclose.
C. A. Anderson, MD, FAAN	Dr. Anderson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Anderson has received research support from Department of Defense. Dr. Anderson has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Question writer for the pediatrics boards with American Board of Pediatrics. An immediate family member of Dr. Anderson has received personal compensation in the range of $500-$4,999 for serving as a Lecturer at pediatric conference with Creighton University .
Erin Dennis, MD	Dr. Dennis has nothing to disclose.
Valentina Floris, MD	Dr. Floris has nothing to disclose.
David Baker	No disclosure on file
Tia Chakraborty, MD	Dr. Chakraborty has nothing to disclose.
Anna K. Bonkhoff, MD	Dr. Bonkhoff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroImage Clinical (Elsevier).
Emily C. Johnson, MD	No disclosure on file
Carlos Henrique F. Camargo, MD, PhD, MSc, FAAN	Dr. Camargo has nothing to disclose.
Noor Mahmoud, MD	Dr. Mahmoud has nothing to disclose.
Muhammad Masood Ahmed, PhD	Dr. Ahmed has nothing to disclose.
Rui Kleber Martins-Filho	No disclosure on file
Lon Schneider, MD	Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immue. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Athira. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha-cognition. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corium. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortexyme. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurim Ltd. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Eli Lilly. The institution of Dr. Schneider has received research support from Biogen. The institution of Dr. Schneider has received research support from Biohaven.
Natalia Romano Spica	Ms. Romano Spica has nothing to disclose.
Krithishree S.	No disclosure on file
Pietro Zara, MD	Dr. Zara has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Brian C. Florenzo	Mr. Florenzo has received research support from The Foundation of the Consortium of Multiple Sclerosis Centers.
Catherine M. Amlie-Lefond, MD, FAAN	Dr. Amlie-Lefond has nothing to disclose.
Alice Accorroni, MD, PhD	No disclosure on file
Lars Bergmann	Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Omar Ladhani	Omar Ladhani has received personal compensation for serving as an employee of AbbVie. Omar Ladhani has received stock or an ownership interest from AbbVie.
Klaus Schmierer, MD, PhD	Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AXDEV. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MedScape. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDiem. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Academy. Dr. Schmierer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck KGaA. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffmann-La Roche AG. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Schmierer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Taylor R. Anderson, MD	Dr. Anderson has nothing to disclose.
Lily Wong-Kisiel, MD, FAAN	Dr. Wong-Kisiel has nothing to disclose.
Zain Ashary, MD	Dr. Ashary has nothing to disclose.
Tejinder Singh, MD	Dr. Singh has nothing to disclose.
Veronica A. Moreno Gomez, MD	Dr. Moreno Gomez has nothing to disclose.
Liqi Shu, MD	Dr. Shu has nothing to disclose.
Neishay Ayub, MD	The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Sukriye Damla Kara, MD	Dr. Kara has nothing to disclose.
Sachin M. Bhagavan, MD	Dr. Bhagavan has nothing to disclose.
Joseph N. Gonzalez	Mr. Gonzalez has nothing to disclose.